Is extracranial-intracranial bypass surgery effective in certain patients?
Related Experiment Video
Updated: Jul 20, 2026
Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
Published on: August 11, 2015
Sepideh Amin-Hanjani1, Fady T Charbel
1Department of Neurosurgery, University of Illinois at Chicago, Neuropsychiatric Institute (MC 799), 912 South Wood Street, Chicago, IL 60612, USA. hanjani@uic.edu
Insights
Surgical revascularization for ischemic disease is debated. While some studies show no benefit, selected patients may still benefit from bypass procedures, especially for moyamoya disease.
Area of Science:
- Neurosurgery
- Vascular Surgery
- Neurology
Background:
- The efficacy of surgical revascularization for ischemic disease is controversial.
- Previous trials like the EC-IC bypass trial yielded inconclusive results for superficial temporal artery-middle cerebral artery (STA-MCA) bypass.
- Despite controversy, specific patient groups may benefit from these procedures.
Purpose of the Study:
- To evaluate the current role of surgical revascularization in managing ischemic disease.
- To discuss the indications for bypass surgery in specific neurological conditions.
- To provide an updated perspective on bypass as a treatment option.
Main Methods:
- Review of existing literature and clinical evidence.
- Analysis of outcomes in patients undergoing surgical revascularization.
- Comparison of bypass surgery with medical therapy in selected cases.
Main Results:
- Evidence suggests potential benefits of bypass in selected ischemic disease patients.
- Superficial temporal artery-middle cerebral artery (STA-MCA) bypass did not show superiority over medical therapy in a major trial.
- Bypass surgery is a primary treatment for moyamoya disease and planned vessel sacrifice.
Conclusions:
- Surgical revascularization, particularly bypass, remains a critical option for specific patient populations.
- Careful patient selection is crucial for successful outcomes in ischemic cerebrovascular disease.
- Further research may clarify the precise role of bypass in various ischemic conditions.
Abstract:
The role of surgical revascularization for patients who have ischemic disease remains controversial. Despite the previous EC-IC bypass trial that failed to demonstrate the benefit from STA-MCA bypass compared with medical therapy, however, there is mounting evidence that the procedure should be considered in selected patients. Bypass remains a mainstay of treatment in moyamoya disease and in flow replacement in the setting of planned vessel sacrifice.